83 related articles for article (PubMed ID: 8894186)
1. Influence of levosimendan, pimobendan, and milrinone on the regional distribution of cardiac output in anaesthetized dogs.
Pagel PS; Hettrick DA; Warltier DC
Br J Pharmacol; 1996 Oct; 119(3):609-15. PubMed ID: 8894186
[TBL] [Abstract][Full Text] [Related]
2. Comparison of Levosimendan Versus Milrinone After the Arterial Switch Operation for Infants ≤3 kg.
Joshi RK; Joshi R; Aggarwal N; Agarwal M; Siddartha CR; Relan J; Kumar A; Modi M; Chug P
World J Pediatr Congenit Heart Surg; 2024 May; ():21501351241239306. PubMed ID: 38766718
[No Abstract] [Full Text] [Related]
3. A multimodal tissue perfusion measurement approach for the evaluation of the effect of pimobendan, an inodilator, in a porcine sepsis model.
Magnin M; Gavet M; Ngo TT; Louzier V; Victoni T; Ayoub JY; Allaouchiche B; Bonnet-Garin JM; Junot S
Microvasc Res; 2024 Jul; 154():104687. PubMed ID: 38614155
[TBL] [Abstract][Full Text] [Related]
4. The role of cAMP- and cGMP-dependent protein kinases in the cardiac actions of the new calcium sensitizer, levosimendan.
Haikala H; Kaheinen P; Levijoki J; Lindén IB
Cardiovasc Res; 1997 Jun; 34(3):536-46. PubMed ID: 9231037
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics of levosimendan in healthy volunteers and patients with congestive heart failure.
Sandell EP; Hayha M; Antila S; Heikkinen P; Ottoila P; Lehtonen LA; Pentikainen PJ
J Cardiovasc Pharmacol; 1995; 26 Suppl 1():S57-62. PubMed ID: 8907132
[TBL] [Abstract][Full Text] [Related]
6. Haemodynamic Effects of Pimobendan during General Anaesthesia in Healthy Senior Dogs: A Prospective, Randomised, Triple-Blinded, Placebo-Controlled Clinical Study.
Sández I; Redondo JI; Donati PA; Gómez J
Animals (Basel); 2023 Jun; 13(13):. PubMed ID: 37443908
[TBL] [Abstract][Full Text] [Related]
7. Hemodynamic effect of pimobendan following intramuscular and intravenous administration in healthy dogs: A pilot study.
Enokizono M; Mandour AS; Komeda S; Goya S; Takeuchi A; Katoh K; Yairo A; Yilmaz Z; Shimada K; Tanaka R
Front Vet Sci; 2022; 9():969304. PubMed ID: 36311676
[TBL] [Abstract][Full Text] [Related]
8. Effect of standard-dose and high-dose pimobendan on select indices of renal and cardiac function in dogs with American College of Veterinary Internal Medicine stage B2 myxomatous mitral valve disease.
Kaplan JL; Visser LC; Gunther-Harrington CT; Ontiveros ES; Wittenburg LA; Palm CA; Stern JA
J Vet Intern Med; 2022 Nov; 36(6):1892-1899. PubMed ID: 36098206
[TBL] [Abstract][Full Text] [Related]
9. Protective Effect on Pancreatic Acinar Cell by Maintaining Cardiac Output in Canine Heart Failure Model With Decreased Pancreatic Blood Flow.
Yoshimura A; Ohmori T; Hirao D; Kishimoto M; Iwanaga T; Miura N; Suzuki K; Fukushima R
Front Vet Sci; 2022; 9():925847. PubMed ID: 35909700
[TBL] [Abstract][Full Text] [Related]
10. Preliminary Bioequivalence of an Oral Pimobendan Solution Formulation with Reference Solution Formulation in Beagle Dogs.
Saengklub N; Boonyarattanasoonthorn T; Kijtawornrat A; Chantasart D
Vet Sci; 2022 Mar; 9(3):. PubMed ID: 35324869
[TBL] [Abstract][Full Text] [Related]
11. Management of Chronic Congestive Heart Failure Caused by Myxomatous Mitral Valve Disease in Dogs: A Narrative Review from 1970 to 2020.
Bagardi M; Zamboni V; Locatelli C; Galizzi A; Ghilardi S; Brambilla PG
Animals (Basel); 2022 Jan; 12(2):. PubMed ID: 35049831
[TBL] [Abstract][Full Text] [Related]
12. Levosimendan-induced venodilation is mediated by opening of potassium channels.
Burkhoff D; Rich S; Pollesello P; Papp Z
ESC Heart Fail; 2021 Dec; 8(6):4454-4464. PubMed ID: 34716759
[TBL] [Abstract][Full Text] [Related]
13. Pharmacodynamics and Pharmacokinetics of Injectable Pimobendan and Its Metabolite, O-Desmethyl-Pimobendan, in Healthy Dogs.
Pichayapaiboon P; Tantisuwat L; Boonpala P; Saengklub N; Boonyarattanasoonthorn T; Khemawoot P; Kijtawornrat A
Front Vet Sci; 2021; 8():656902. PubMed ID: 34490386
[No Abstract] [Full Text] [Related]
14. Comparison Between Two Pharmacologic Strategies to Alleviate Rewarming Shock: Vasodilation vs. Inodilation.
Håheim B; Kondratiev T; Dietrichs ES; Tveita T
Front Med (Lausanne); 2020; 7():566388. PubMed ID: 33282886
[TBL] [Abstract][Full Text] [Related]
15. Levosimendan Efficacy and Safety: 20 years of SIMDAX in Clinical Use.
Papp Z; Agostoni P; Alvarez J; Bettex D; Bouchez S; Brito D; Černý V; Comin-Colet J; Crespo-Leiro MG; Delgado JF; Édes I; Eremenko AA; Farmakis D; Fedele F; Fonseca C; Fruhwald S; Girardis M; Guarracino F; Harjola VP; Heringlake M; Herpain A; Heunks LM; Husebye T; Ivancan V; Karason K; Kaul S; Kivikko M; Kubica J; Masip J; Matskeplishvili S; Mebazaa A; Nieminen MS; Oliva F; Papp JG; Parissis J; Parkhomenko A; Põder P; Pölzl G; Reinecke A; Ricksten SE; Riha H; Rudiger A; Sarapohja T; Schwinger RH; Toller W; Tritapepe L; Tschöpe C; Wikström G; von Lewinski D; Vrtovec B; Pollesello P
Card Fail Rev; 2020 Mar; 6():e19. PubMed ID: 32714567
[TBL] [Abstract][Full Text] [Related]
16. Levosimendan Efficacy and Safety: 20 Years of SIMDAX in Clinical Use.
Papp Z; Agostoni P; Alvarez J; Bettex D; Bouchez S; Brito D; Černý V; Comin-Colet J; Crespo-Leiro MG; Delgado JF; Édes I; Eremenko AA; Farmakis D; Fedele F; Fonseca C; Fruhwald S; Girardis M; Guarracino F; Harjola VP; Heringlake M; Herpain A; Heunks LMA; Husebye T; Ivancan V; Karason K; Kaul S; Kivikko M; Kubica J; Masip J; Matskeplishvili S; Mebazaa A; Nieminen MS; Oliva F; Papp JG; Parissis J; Parkhomenko A; Põder P; Pölzl G; Reinecke A; Ricksten SE; Riha H; Rudiger A; Sarapohja T; Schwinger RHG; Toller W; Tritapepe L; Tschöpe C; Wikström G; Lewinski DV; Vrtovec B; Pollesello P
J Cardiovasc Pharmacol; 2020 Jul; 76(1):4-22. PubMed ID: 32639325
[TBL] [Abstract][Full Text] [Related]
17. Non-pulsatile blood flow is associated with enhanced cerebrovascular carbon dioxide reactivity and an attenuated relationship between cerebral blood flow and regional brain oxygenation.
Veraar CM; Rinösl H; Kühn K; Skhirtladze-Dworschak K; Felli A; Mouhieddine M; Menger J; Pataraia E; Ankersmit HJ; Dworschak M
Crit Care; 2019 Dec; 23(1):426. PubMed ID: 31888721
[TBL] [Abstract][Full Text] [Related]
18. Multiorgan Drug Action of Levosimendan in Critical Illnesses.
Pan J; Yang YM; Zhu JY; Lu YQ
Biomed Res Int; 2019; 2019():9731467. PubMed ID: 31641670
[TBL] [Abstract][Full Text] [Related]
19. Inotropic effects of a single intravenous recommended dose of pimobendan in healthy dogs.
Hori Y; Taira H; Nakajima Y; Ishikawa Y; Yumoto Y; Maekawa Y; Oshiro A
J Vet Med Sci; 2019 Jan; 81(1):22-25. PubMed ID: 30404952
[TBL] [Abstract][Full Text] [Related]
20. Levosimendan in Acute and Advanced Heart Failure: an Expert Perspective on Posology and Therapeutic Application.
Bouchez S; Fedele F; Giannakoulas G; Gustafsson F; Harjola VP; Karason K; Kivikko M; von Lewinski D; Oliva F; Papp Z; Parissis J; Pollesello P; Pölzl G; Tschöpe C
Cardiovasc Drugs Ther; 2018 Dec; 32(6):617-624. PubMed ID: 30402660
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
